BRIEF-Sotera Health Q4 Adjusted EPS USD 0.21 Vs. IBES Estimate USD 0.2

Reuters

2025/02/27

Feb 27 (Reuters) - Sotera Health Q4 revenue USD 290.203 million vs. IBES estimate USD 290.9 million.

Q4 gross profit USD 164.365 million
Q4 pretax profit USD 44.964 million vs. IBES estimate USD 81.2 million
Q4 net income USD 12.323 million
Q4 operating income USD 87.146 million
Q4 adjusted EBITDA USD 153 million vs. IBES estimate USD 151.7 million
outlook FY revenue growth 4.5-6.5%

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2514805876"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2514805876\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2514805876?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-27 20:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2514805876","market":"nz","top_or_hot":-1,"title":"BRIEF-Sotera Health Q4 Adjusted EPS USD 0.21 Vs. IBES Estimate USD 0.2","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\">\n<head>\n<meta/>\n<title>BRIEF-Sotera Health Q4 Adjusted EPS USD 0.21 Vs. IBES Estimate USD 0.2</title>\n</head>\n<body>\n<p>Feb 27 (Reuters) - Sotera Health Q4 revenue USD 290.203 million vs. IBES estimate USD 290.9 million.</p>\n<ul>\n<li>Q4 gross profit USD 164.365 million</li>\n<li>Q4 pretax profit USD 44.964 million vs. IBES estimate USD 81.2 million</li>\n<li>Q4 net income USD 12.323 million</li>\n<li>Q4 operating income USD 87.146 million</li>\n<li>Q4 adjusted EBITDA USD 153 million vs. IBES estimate USD 151.7 million</li>\n<li>outlook FY revenue growth 4.5-6.5%</li>\n</ul>\n</body>\n</html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Sotera Health Q4 Adjusted EPS USD 0.21 Vs. IBES Estimate USD 0.2</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Sotera Health Q4 Adjusted EPS USD 0.21 Vs. IBES Estimate USD 0.2\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-02-27 20:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\">\n<head>\n<meta/>\n<title>BRIEF-Sotera Health Q4 Adjusted EPS USD 0.21 Vs. IBES Estimate USD 0.2</title>\n</head>\n<body>\n<p>Feb 27 (Reuters) - Sotera Health Q4 revenue USD 290.203 million vs. IBES estimate USD 290.9 million.</p>\n<ul>\n<li>Q4 gross profit USD 164.365 million</li>\n<li>Q4 pretax profit USD 44.964 million vs. IBES estimate USD 81.2 million</li>\n<li>Q4 net income USD 12.323 million</li>\n<li>Q4 operating income USD 87.146 million</li>\n<li>Q4 adjusted EBITDA USD 153 million vs. IBES estimate USD 151.7 million</li>\n<li>outlook FY revenue growth 4.5-6.5%</li>\n</ul>\n</body>\n</html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SHC","symbol_name":"Sotera Health Company","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nPLX4DE3E5:1","article_id":"2514805876","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2514805876","pubTimestamp":1740657682,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Feb 27  - Sotera Health Q4 revenue USD 290.203 million vs. IBES estimate USD 290.9 million.Q4 pretax profit USD 44.964 million vs. IBES estimate USD 81.2 million. Q4 adjusted EBITDA USD 153 million vs. IBES estimate USD 151.7 million","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"SHC":"Sotera Health Company"},"translate_title":"简介-Sotera Health第四季度调整后每股收益为0.21美元，而IBES预估为0.2美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SHC":0.9},"content_text":"BRIEF-Sotera Health Q4 Adjusted EPS USD 0.21 Vs. IBES Estimate USD 0.2\n\n\nFeb 27 (Reuters) - Sotera Health Q4 revenue USD 290.203 million vs. IBES estimate USD 290.9 million.\n\nQ4 gross profit USD 164.365 million\nQ4 pretax profit USD 44.964 million vs. IBES estimate USD 81.2 million\nQ4 net income USD 12.323 million\nQ4 operating income USD 87.146 million\nQ4 adjusted EBITDA USD 153 million vs. IBES estimate USD 151.7 million\noutlook FY revenue growth 4.5-6.5%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}